STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] Celanese Corporation Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Edward G. Galante, a director of Celanese Corporation (CE), reported acquisition of phantom stock units on 08/11/2025 under the company’s 2008 Deferred Compensation Plan. The Form 4 records an acquisition (A) of phantom stock representing 6,797.555 underlying common shares at a reported per-unit value of $47.42, with the ownership form marked as Direct (D).

Each phantom share is described as the right to receive one share of common stock and represents dividend equivalents deferred under the Plan; those units become payable in shares following the termination of the reporting person’s service as a director. The Form 4 is signed by an attorney-in-fact for the reporting person.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Director received deferred-compensation phantom units equal to 6,797.555 shares, recorded as dividend equivalents under the company's plan.

The filing documents a non-cash compensation credit rather than an open-market trade. The reported 6,797.555 phantom units are described explicitly as dividend equivalents under the 2008 Deferred Compensation Plan and are payable in common shares upon the director's termination of service. The per-unit figure shown is $47.42, which is the reported value on the Form 4. For compensation accounting and disclosure, this transaction increases the director's deferred equity-linked entitlement but does not by itself indicate current share issuance or sale activity.

TL;DR: Routine director deferred-compensation credit disclosed; items are grant-type phantom units convertible to shares after service ends.

The Form 4 identifies Edward G. Galante as a director and reports the acquisition of phantom stock units that represent the right to receive one share each. The filing clarifies these units are dividend equivalents under the company’s 2008 plan and will be settled in shares following termination of service. This is a standard disclosure for deferred equity arrangements and conveys information about director compensation timing and potential future dilution if and when settlement occurs. The report was executed by an attorney-in-fact for the reporting person.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GALANTE EDWARD G

(Last) (First) (Middle)
C/O CELANESE CORPORATION
222 W. LAS COLINAS BLVD., SUITE 900N

(Street)
IRVING TX 75039

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Celanese Corp [ CE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Phantom Stock (1) 08/11/2025 A 4.3 (2) (2) Common Stock 4.3 $47.42 6,797.555 D
Explanation of Responses:
1. Each share of phantom stock represents the right to receive one share of Common Stock.
2. The reported phantom stock represents dividend equivalents on compensation deferred under the Company's 2008 Deferred Compensation Plan (the "Plan"). The shares of phantom stock become payable in shares of Common Stock, as provided in the Plan, following the termination of the reporting person's service as a director of the Company.
Remarks:
/s/ Christine Dryden, Attorney-in-Fact for Edward G. Galante 08/13/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Celanese (CE) insider Edward G. Galante report on Form 4?

The Form 4 reports an acquisition of phantom stock units on 08/11/2025 representing 6,797.555 underlying common shares at a reported per-unit value of $47.42.

What does each phantom stock unit represent in this filing?

Each phantom stock unit represents the right to receive one share of Common Stock, as stated in the Form 4 explanation.

Under which plan were these phantom units granted?

The reported phantom stock units are described as dividend equivalents deferred under the company's 2008 Deferred Compensation Plan.

When will the phantom stock units be paid out in shares?

The Form 4 states the phantom stock become payable in shares following the termination of the reporting person's service as a director.

Who signed the Form 4 on behalf of Edward G. Galante?

The Form 4 is signed by Christine Dryden, Attorney-in-Fact for Edward G. Galante.
Celanese Corp Del

NYSE:CE

CE Rankings

CE Latest News

CE Latest SEC Filings

CE Stock Data

4.52B
109.02M
0.43%
107.35%
6.16%
Chemicals
Plastic Material, Synth Resin/rubber, Cellulos (no Glass)
Link
United States
IRVING